#news #biotech Seeking an edge in a fiercely-fought field, Bristol-Myers pays Halozyme $105M to access I-O delivery tech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Seeking an edge in a fiercely-fought field, Bristol-Myers pays Halozyme $105M to access I-O delivery tech .Bristol-Myers Squibb has paid Halozyme $105 million upfront to access drug delivery technology. The agreement positions Bristol-Myers to develop subcutaneous formulations of molecules against PD-1 and 10 other immuno-oncology targets.

from FierceBiotech: Biotech http://ift.tt/2x3G2MC